Key result
External cephalic version under spinal anesthesia achieved a 76% success rate, translating to an estimated annual cost savings of $5.9 million for the Israeli healthcare system.
Why the study?
Does external cephalic version under regional anesthesia improve success rates and cost-effectiveness in pregnant women with breech presentation at term?
Does external cephalic version under regional anesthesia improve success rates and cost-effectiveness in pregnant women with breech presentation at term?
Answers are grounded in this paper and cite their sources.
External cephalic version under regional anesthesia appears to be a cost-effective strategy to increase success rates and reduce cesarean deliveries for breech presentation.
Breech presentation is encountered in 3 to 4% of term pregnancies and has been a significant driver of the increased rate of cesarean deliveries over the last 4 decades. External cephalic version (ECV) is recommended at term by most professional organizations in an effort to reduce the prospect of cesarean deliveries. The authors propose the use of regional anesthesia to increase efficacy and reduce cost in the care of patients who undergo ECV in an effort to convert a breech presentation to a vertex counterpart. Despite emerging evidence of the advantages, obstacles to more comprehensive implementation of this approach continue to exist, which include patient acceptance, provider experience, and safety concerns. The addition of tocolytics and use of regional anesthesia for secondary ECV efforts have also been considered as options to increase success and reduce cost. This is a commentary on http://www.ijhpr.org/content/3/1/5.
No takes yet. Share an insight, caveat, or question.
O'Brien et al. (2014) conducted an editorial in Breech presentation. External cephalic version using spinal anesthesia vs. External cephalic version without anesthesia or scheduled cesarean delivery was evaluated on Successful version. External cephalic version under spinal anesthesia achieved a 76% success rate, translating to an estimated annual cost savings of $5.9 million for the Israeli healthcare system.
Synapse has enriched 10 related papers. Consider them for comparative context: